Real-time enrollment status for this locally recurrent skin squamous cell carcinoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 10:53 PM UTC
| NCT Number | NCT07042295 |
| Recruiting Status | Recruiting |
| Condition | Locally Recurrent Skin Squamous Cell Carcinoma |
| Phase | PHASE2 |
| Target Enrollment | 86 participants |
| Active Locations | 51 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 29, 2026: Clinical trial NCT07042295 is currently recruiting participants. This phase2 study for locally recurrent skin squamous cell carcinoma is actively seeking new participants at 51 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07042295 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07042295 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.